Hard gelatin and hypromellose (HPMC) capsules: Estimation of rupture time by real-time dissolution spectroscopy

被引:15
作者
El-Malah, Yasser
Nazzal, Sami
Bottom, Carey B.
机构
[1] Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Coll Pharm, Monroe, LA 71209 USA
[2] Qualicaps Inc, Business Dev & Tech Affairs, Whitsett, NC USA
关键词
hard gelatin capsules; hypromellose capsules; HPMC capsules; real-time spectroscopy; dissolution; dosage forms;
D O I
10.1080/03639040600685183
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objective of this study was to measure rupture time of gelatin and hypromellose (hydroxypropyl methylcellulose or HPMC) capsules using a novel approach based on real-time dissolution spectroscopy. Rupture time was measured in standard dissolution apparatus at a constant temperature using a dip-type fiber-optic probe. Labrasol released from the capsules was treated as the marker of the rupture process. Light scatter generated by the emulsified labrasol was detected by an ultrafast monochromator at scan rates approximating 24,000 nm/min. This technique was validated by measuring the dissolution time of gelatin capsules. Rupture times of hypromellose capsules were studied as a function of capsule size, capsule grade, and dissolution medium. Statistical correlations were analyzed by ANOVA. Rupture time of hypromellose capsules was dependent on both the medium and the grade of the capsule, and was independent of capsule size. The composition of the dissolution medium contributes to the rupture time of the capsules and should be considered when fast release and quick biological response is desired. Release delay, however, may not manifest itself in vivo and the time to maximum plasma concentration may not be significant.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 17 条
[1]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[2]  
BONFERONI MC, 2001, AAPS PHARMSCITECH, V1, pE15
[3]   PELLICULE FORMATION IN GELATIN CAPSULES [J].
CARSTENSEN, JT ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (20) :2709-2712
[4]  
Chiwele I, 2000, CHEM PHARM BULL, V48, P951
[5]   CROSS-LINKING OF GELATIN CAPSULES AND ITS RELEVANCE TO THEIR IN-VITRO IN-VIVO PERFORMANCE [J].
DIGENIS, GA ;
GOLD, TB ;
SHAH, VP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (07) :915-921
[6]  
ELLIOTT GR, 1972, CLIN PHARMACOL THER, V13, P459
[7]  
Harwood RJ, 1994, HDB PHARM EXCIPIENTS, P229
[8]  
HUTTENRAUCH R, 1971, PHARMAZIE, V26, P107
[9]  
JONES BE, 1972, ACTA PHARM SUEC, V9, P261
[10]   FUELS FOR THE FUTURE - REMOTE GAS CONVERSION [J].
JONES, CA ;
LEONARD, JJ ;
SOFRANKO, JA .
ENERGY & FUELS, 1987, 1 (01) :12-16